Capital Performance Advisors »

Atea Pharmaceuticals shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $103 31 3.35

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Atea Pharmaceuticals

BlackRock
BlackRock
BML Capital Management
EcoR1 Capital
Vanguard Group
Tang Capital Management
Bain Capital Life Sciences Investors
Geode Capital Management
State Street Corporation
Almitas Capital
Renaissance Technologies
Acadian Asset Management
Dimensional Fund Advisors
Northern Trust
Charles Schwab Investment Management

View all funds holding Atea Pharmaceuticals